JMB-HEADER NAUKA RAS RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 52(2018) N 4 p. 629-635; DOI 10.1134/S0026893318040155 Full Text

V.D. Pivovarov1, D.Yu. Ryazantsev1, M.A. Simonova1, T.V. Yegorova1 , S.V. Khlgatian2, S.K. Zavriev1, E.V. Svirshchevskaya1*

Immuno-PCR Assay for Quantitation of Antibodies to Epstein-Barr Virus

1Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997 Russia
2Mechnikov Institute of Vaccines and Sera, Moscow, 105064 Russia

*esvir@mx.ibch.ru
Received - 2017-11-09; Accepted - 2017-12-12

Successful disease prevention and therapy critically depend on timely diagnosis of infections. Quantitative immuno-PCR (qiPCR) technology improves the sensitivity in the detection of antibodies to pathogens. A qiPCR-based assay was developed to determine IgG antibodies to Epstein-Barr virus (EBV) in the human blood serum. EBV nuclear protein 1 fragment (pEBV) was expressed in Escherichia coli. A synthetic single-stranded deoxyribonucleotide was conjugated to streptavidin, and the conjugate was used to detect рEBV-IgG1-biotin complexes by qiPCR. The IgG1 titers determined by qiPCR were compared to the results of enzyme-linked immunosorbent assay (ELISA). The sensitivity of qiPCR was one order of magnitude higher than that of ELISA. Thus, a highly sensitive qiPCR-based assay was developed to quantitate antibodies specific to the recombinant EBV antigen.

quantitative immuno-PCR, ELISA, recombinant proteins, Epstein-Barr virus, EBNA1, IgG1



JMB-FOOTER RAS-JOURNALS